Global Drug Discovery Services Market is expected to reach USD 18.15 Billion by 2026 from USD XX Billion in 2018 at CAGR of XX%.
Increasing research & development expenditure, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles, growing awareness about chronic diseases, increasing patient pool, unmet medical needs, patent expiration of blockbuster drugs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement, and increasing demand for outsourcing of analytical testing and clinical trial services is driving the drug discovery services market. High cost of drug discovery and development will restrain the market growth.
Drug Discovery Services Market Key Trends, By Process:
• Target Selection
• Target Validation
• Hit-To-Lead Identification
• Lead Optimization
• Candidate Validation
Drug Discovery Services Market Key Trends, By Therapeutic Area:
• Oncology
• Neurology
• Cardiovascular Diseases
• Respiratory Disorders
• Diabetes
• Other Therapeutic Areas
Drug Discovery Services Market Key Trends, By Drug Type:
• Small Molecules
• Biologics
Drug Discovery Services Market Key Trends, By Type:
• Medicinal Chemistry
• Biology Services
• Drug Metabolism and Pharmacokinetics (DMPK)
Drug Discovery Services Market Key Trends, By Geography:
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America.
Global Drug Discovery Services Market : Global Industry Analysis and Forecast 2026
Maximize Market Research has comprehensively analysed drug discovery services market emphasising on each and every aspect. The driving forces as well as considerable restraints have been explained in depth to attain a balanced scenario. Segment wise market size and market share during the forecast years is duly addressed to portray the probable picture of this exuberant industry. The competitive landscape comprising of key innovators, service providers, market giants as well as niche players is studied and analysed extensively with respect to their strengths, weaknesses as well as value addition prospects. Report presents significant case studies along with the success stories to motivate and guide the like minds. In addition, Report displays current consolidation trends with respect to prominent mergers and acquisitions, consequent Market fragmentation, new trends and dynamics in partnerships, emerging business models. This will enable the reader to comprehend whole drug discovery services market with utmost ease and clarity.